ACS Medicinal Chemistry Letters | Vol 12, No 12
pubs.acs.org › toc › amclctArtificial intelligence (AI) generated image of antibiotic drugs penetrating and killing bacteria. The AI algorithm was processing keywords from the abstract of the work on new disulfide functionalized vancomycin antibiotics that display potent activity on resistant bacterial strains, potentially related to increased affinity to membranes based on the disulfide scaffold. View the article.
ACS Medicinal Chemistry Letters | Vol 12, No 3
https://pubs.acs.org/toc/amclct/12/311.03.2021 · ACS Medicinal Chemistry Letters 2021, 12, 3, 494-501 (Letter) Publication Date (Web): March 2, 2021. Abstract. Full text. PDF. ABSTRACT. Indoleamine 2,3-dioxygenase 1 (IDO1) has been identified as a target for small-molecule immunotherapy for the treatment of a variety of cancers including renal cell carcinoma and metastatic melanoma.
ACS Medicinal Chemistry Letters
pubs.acs.org › journal › amclctNov 10, 2015 · ACS Medicinal Chemistry Letters, ACS Pharmacology & Translational Science, and Journal of Medicinal Chemistry welcome submissions to this joint Virtual Special Issue. Submission deadline: July 31, 2022. Read the Editorial to learn more
ACS Medicinal Chemistry Letters
https://pubs.acs.org/journal/amclct10.11.2015 · ACS Medicinal Chemistry Letters, ACS Pharmacology & Translational Science, and Journal of Medicinal Chemistry welcome submissions to this joint Virtual Special Issue. Submission deadline: July 31, 2022. Read the Editorial to learn more. Epigenetics: Targeting Chromatin- and RNA- Modifications.